PCHS stands for "Peripheral Chemo-Hyperthermia System." It is a medical term used to describe a type of treatment modality typically utilized in the field of oncology. The Peripheral Chemo-Hyperthermia System refers to a medical device or therapy that combines chemotherapy and hyperthermia to provide targeted treatment for cancer.
In this context, chemotherapy denotes the administration of drugs that help fight cancerous cells and prevent their growth and division. Hyperthermia, on the other hand, refers to the deliberate elevation of body temperature in a controlled manner to assist in destroying cancer cells or make them more susceptible to treatment.
The PCHS system typically consists of various components, including a heating device, circulation system, and a catheter or vascular access to deliver the chemotherapy agents directly to the affected area. The heat generated by the device helps enhance the efficacy of chemotherapy drugs, as higher temperatures can increase drug uptake by tumor cells and promote their destruction.
This combination therapy is often used when traditional cancer treatment methods, such as surgery, radiation therapy, or single-agent chemotherapy, may not be sufficient to combat the disease. Moreover, PCHS treatment can be utilized for various types of cancer, including but not limited to liver cancer, pancreatic cancer, and colorectal cancer.
Overall, PCHS is a promising therapeutic approach that aims to improve cancer treatment outcomes by leveraging the synergistic effects of heat and chemotherapy to target tumor cells more effectively while minimizing damage to healthy tissues.
